Simplify Exchange Traded Funds · net assets $69.4M · 48 holdings as of March 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 97.0% · DBT: 93.8% · RA: -90.8%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $167K | $492K | $653K |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $0 | $0 | $2.07M |
| Net realized gain (non-derivative) | $-440K | $1.73M | $-118K |
| Net unrealized appreciation (non-derivative) | $-1.44M | $1.98M | $-3.99M |
The three months of the reporting period, as filed; month 3 ends March 31, 2026.
| Tenor | Investment grade | Non-investment grade |
|---|---|---|
| 3 months | $0 | $23.6 |
| 1 year | $0 | $30 |
| 5 years | $0 | $0 |
| 10 years | $0 | $0 |
| 30 years | $0 | $0 |
| Holding | Value | % of net assets |
|---|---|---|
| United States Treasury Bills DBT | $64.5M | 92.93% |
| Plains Gp Holdings LP EC | $30.9M | 44.55% |
| Achieve Life Science Inc EC | $3.48M | 5.02% |
| Phathom Pharmaceuticals Inc EC | $2.92M | 4.20% |
| Delcath Systems Inc. EC | $2.42M | 3.49% |
| Abeona Therapeutics Inc. EC | $2.24M | 3.23% |
| Celldex Therapeutics Inc. EC | $2.19M | 3.16% |
| Milestone Pharmaceuticals Inc EC | $1.79M | 2.58% |
| Oculis Holding Ag EC | $1.77M | 2.56% |
| Leonabio Inc. EC | $1.53M | 2.21% |
| Corcept Therapeutics Inc. EC | $1.52M | 2.19% |
| Kyverna Therapeutics Inc EC | $1.49M | 2.15% |
| Inventiva Sa EC | $1.26M | 1.82% |
| Viridian Therapeutics Inc EC | $1.1M | 1.59% |
| Aquestive Therapeutics Inc EC | $972K | 1.40% |
| Vor Biopharma Inc EC | $955K | 1.38% |
| Orchestra Biomed Holdings Inc EC | $932K | 1.34% |
| Zevra Therapeutics Inc EC | $897K | 1.29% |
| Compass Pathways PLC EC | $880K | 1.27% |
| Telesat Canada /telesat LLC DBT | $800K | 1.15% |
| Trevi Therapeutics Inc EC | $780K | 1.13% |
| Ocular Therapeutix Inc EC | $762K | 1.10% |
| Sab Biotherapeutics Inc EC | $717K | 1.03% |
| Upstream Bio Inc EC | $700K | 1.01% |
| Eyepoint Inc. EC | $690K | 0.99% |
| 4d Molecular Therapeutics Inc EC | $656K | 0.95% |
| Palisade Bio Inc EC | $613K | 0.88% |
| Zealand Pharma As EC | $569K | 0.82% |
| Kalaris Therapeutics Inc EC | $504K | 0.73% |
| Immunic Inc. EC | $487K | 0.70% |
| Coherus Oncology Inc. EC | $428K | 0.62% |
| Akero Therapeutics Inc EC | $427K | 0.62% |
| Corvus Pharmaceuticals Inc EC | $296K | 0.43% |
| Ovid Therapeutics Inc EC | $290K | 0.42% |
| Artiva Biotherapeutics Inc EC | $150K | 0.22% |
| Connect Biopharma Holdings Ltd EC | $140K | 0.20% |
| Chinook Therapeutics Inc EC | $2.5K | 0.00% |
| Eiger Biopharmaceuticals Inc EC | $900 | 0.00% |
| Milestone Pharmace Wts EC | $1.84 | 0.00% |
| Milestone Pharmace Wts EC | $1.84 | 0.00% |
| Achieve Life Science Inc EC | $0.97 | 0.00% |
| Jasper Therapeutic Wts EC | $0.61 | 0.00% |
| Wts - Tenaya Therapeutics EC | $0.56 | 0.00% |
| Quoin Pharmaceutic Wts EC | $0.03 | 0.00% |
| Quoin Pharmaceutic Wts EC | $0.03 | 0.00% |
| Quoin Pharmaceutic Wts EC | $0.03 | 0.00% |
| Quoin Pharmaceutic Wts EC | $0.03 | 0.00% |
| Morgan Stanley & Co. LLC RA | $-63.2M | -91.06% |
Loading...
